Key result
Female sex in AF is linked to ~31% lower odds of normal quality of life.
Why the study?
Sex-related disparities in AF are increasingly recognized, but data on Chinese AF patients were limited.
Does female sex affect symptom presentation, health-related quality of life, and treatment utilization compared with male sex in Chinese patients with non-valvular atrial fibrillation?
Cohort (n=14,723)
Yes
Does female sex affect symptom presentation, health-related quality of life, and treatment utilization compared with male sex in Chinese patients with non-valvular atrial fibrillation?
Answers are grounded in this paper and cite their sources.
In a large Chinese atrial fibrillation registry, women experienced more severe symptoms and worse quality of life than men but received less rhythm-control treatment under age 75, while oral anticoagulation was markedly underused in both sexes.
BACKGROUND:There is a growing recognition of sex-related disparities in atrial fibrillation (AF). However, limited data is available in Chinese AF patients. MATERIAL AND METHODS:We compared symptoms, quality of life (QoL), and treatment of AF according to sex from the China AF Registry study. RESULTS:We studied 14 723 patients with non-valvular AF, of whom 5645 patients (38.3%) were female. Women were older than men (67.5±10.6 vs. 62.2±12.2). Compared to men, women had more comorbidities and a higher proportion of CHA₂DS₂-VASC score ≥2. Women with AF experienced more severe or disabling symptoms than men (33.7% vs. 22.9% in age <75 group; 40.3% vs. 28.7% in age ≥75 group; both P<0.0001). After multivariate analysis, women with AF still had lower QoL (OR 0.69; 95%CI, 0.63–0.76; P<0.0001). Women tended to have lower rates of ablation and rhythm-control drug use in those aged <75 years. Oral anticoagulant use was low and had no sex difference in AF patients with a CHA₂DS₂-VASC score ≥2. CONCLUSIONS:In Chinese AF patients, women were older and more symptomatic, and had worse QoL. Despite all these differences, women tended to receive less rhythm-control treatment in those aged <75 years. Oral anticoagulant was substantially underused in high stroke risk patients, regardless of sex.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) conducted a cohort in Non-valvular atrial fibrillation (n=14,723). Female sex vs. Male sex was evaluated on Normal health-related quality of life (overall AFEQT score ≥60) (OR 0.69, 95% CI 0.63-0.76, p=<0.0001). Female patients with atrial fibrillation had lower quality of life compared to male patients after multivariable adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: